MAPT and Cognitive impairment: Clinical and preclinical studies have also revealed that impaired insulin signaling induces tau hyperphosphorylation and that insulin-sensitizing strategies improve cerebrospinal fluid biomarkers of disease in patients with mild cognitive impairment or AD (Hölscher, 2014; Yarchoan et al., 2014; Kim et al., 2015).